Compass, Inc. Announces Initial Public Offering

March 31, 2021 – Compass, Inc. today announced its Initial public offering of 25,000,000 of Class A common stock, to begin trading on the NYSE under the symbol COMP.  Lead underwriters are Goldman Sachs, Morgan Stanley. and Barclays Capital Inc. Company press release. FLG partners: Jennifer Cho and Jeffrey Kuhn.

Read More
Jumio Raises $150M in Private Equity

March 23, 2021 – Jumio, the leading provider of AI-powered end-to-end identity verification and eKYC solutions, today announced it secured a $150 million investment from Great Hill Partners, a private equity firm that invests in high-growth, disruptive companies. Press release. FLG partner: Kenton Chow.

Read More
Connect Biopharma Announces IPO

March 18, 2021 – Connect Biopharma Holdings Limited announced its initial public offering of 11,250,000 American Depositary Shares (“ADSs”), representing 11,250,000 ordinary shares of the Company, at a public offering price of US$17.00 per ADS. Company press release. FLG partner: Eric Hall.

Read More
Angion Biomedica Corp. Announces IPO Pricing with Concurrent Private Placement

February 5, 2021 – UNIONDALE, N.Y., Feb. 05, 2021 (GLOBE NEWSWIRE) — Angion Biomedica Corp. (Angion) (NASDAQ:ANGN), a late-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases, has announced the pricing of its initial public offering…Read More

Read More
Angion Biomedica Enters into a Strategic Partnership with Vifor Pharma

November 9, 2020 – BusinessWire – FLG Partner client, Angion Biomedica and Vifor Pharma have signed a license agreement for ANG-3777 in nephrology indications. Through this strategic partnership, Vifor Pharma acquires a worldwide license, excluding Greater China, to late-stage product ANG-3777. ANG-3777 is a first in class small-molecule hepatocyte growth…Read More

Read More